APA (7th ed.) Citation

Gulick, R. M., Smeaton, L. M., D'Aquila, R. T., Eron, J. J., Currier, J. S., Gerber, J. G., . . . Murphy, R. L. (2001). Indinavir, Nevirapine, Stavudine, and Lamivudine for Human Immunodeficiency Virus–Infected, Amprenavir-Experienced Subjects: AIDS Clinical Trials Group Protocol 373. The Journal of infectious diseases, 183(5), 715-721. https://doi.org/10.1086/318820

Chicago Style (17th ed.) Citation

Gulick, Roy M., et al. "Indinavir, Nevirapine, Stavudine, and Lamivudine for Human Immunodeficiency Virus–Infected, Amprenavir-Experienced Subjects: AIDS Clinical Trials Group Protocol 373." The Journal of Infectious Diseases 183, no. 5 (2001): 715-721. https://doi.org/10.1086/318820.

MLA (9th ed.) Citation

Gulick, Roy M., et al. "Indinavir, Nevirapine, Stavudine, and Lamivudine for Human Immunodeficiency Virus–Infected, Amprenavir-Experienced Subjects: AIDS Clinical Trials Group Protocol 373." The Journal of Infectious Diseases, vol. 183, no. 5, 2001, pp. 715-721, https://doi.org/10.1086/318820.